Recent News
Oct 30, 2024
Blueprint Medicines Reports Third Quarter 2024 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full Year Revenue Guidance
Events and presentations
Nov 21, 2024
Jefferies London Healthcare Conference
Nov 18, 2024
Stifel 2024 Healthcare Conference
Our commitment to patients
At Blueprint Medicines, we work together in pursuit of one common goal: to dramatically improve and extend patients’ lives.
read onMeet the Blue Crew
Meet the Blue Crew
Brittany Carroll, Vice President, Therapy Area Lead
I lead a team tasked with guiding our long-term strategy for mast cell diseases. We work across all functions, from research to development to commercial, to map out strategic plans for our therapeutics and targets while ensuring that cross-functional teams are set up to best support the patients we serve.
Read onWe aspire to advance the scientific understanding of disease and pioneer life-changing medicines for patients. To learn more about our scientific leadership and perspectives, visit Our Blueprint.
read on“We ignore traditional boundaries and let science drive us. It’s the only way to revolutionize how we treat serious diseases.”Kate Haviland, Chief Executive Officer
“We ignore traditional boundaries and let science drive us. It’s the only way to revolutionize how we treat serious diseases.”Kate Haviland, Chief Executive Officer
Dare to be different
We believe diversity is the key to unlocking our full potential. We push boundaries and take well-calculated risks, committing courageously and wholeheartedly to what we believe in.
read on